Physician

Ali Reza Tabassian, M.D., PH.D.

According to 2025 Medicare claims, Ali Tabassian, M.D., PH.D. (NPI: 1679535538) practices ophthalmology in the Richmond, VA market, with the plurality of this provider's patient population coming from Chesterfield, VA. This provider's primary affiliated billing organization is VIRGINIA EYE CONSULTANTS INC (NPI: 1992727820; TIN: 541150779) and primary practice location at 23235-1989.

Tabassian's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,138 traditional Medicare patients, billed 22,685 HCPCS/CPT codes, and received $2,320,178 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 593 prescription claims across 200 beneficiaries totaling $24,588 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 9 records totaling $90,251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$2.0M$3.9M2015 Medicare payment: $3,150,730 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,902,592 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,781,741 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $3,300,000 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $3,911,893 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $3,790,124 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,162,487 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,024,296 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $1,904,899 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,320,178 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151,78816,241$3,150,730
20161,79515,746$2,902,592
20171,75213,624$2,781,741
20181,79413,934$3,300,000
20191,77114,509$3,911,893
20201,49312,745$3,790,124
20211,25310,884$3,162,487
20221,2078,445$2,024,296
20231,14510,796$1,904,899
20241,13822,685$2,320,178

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$25K$50K2015 Drug cost: $43,665 (USD; Tot_Drug_Cst)2016 Drug cost: $48,513 (USD; Tot_Drug_Cst)2017 Drug cost: $50,311 (USD; Tot_Drug_Cst)2018 Drug cost: $49,955 (USD; Tot_Drug_Cst)2019 Drug cost: $39,013 (USD; Tot_Drug_Cst)2020 Drug cost: $42,633 (USD; Tot_Drug_Cst)2021 Drug cost: $48,231 (USD; Tot_Drug_Cst)2022 Drug cost: $47,678 (USD; Tot_Drug_Cst)2023 Drug cost: $46,249 (USD; Tot_Drug_Cst)2024 Drug cost: $24,588 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015214699$43,665
2016217751$48,513
2017192671$50,311
2018207669$49,955
2019209607$39,013
2020227679$42,633
2021207651$48,231
2022190559$47,678
2023171565$46,249
2024200593$24,588

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1791,694$658
67028Injection of drug into eye3271,347$93
92014Established patient complete exam of visual system7391,077$87
92134Imaging of retina6411,853$30
92250Photography of the retina580678$26

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1425,301$5,036
LatanoprostLatanoprost1106,061$873
Timolol MaleateTimolol Maleate885,425$854
Brimonidine TartrateBrimonidine Tartrate633,547$792
OfloxacinOfloxacin551,339$659

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$78Genentech USA, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.8$90,173Genentech, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ali Reza Tabassian, M.D., PH.D.?

Tedicare shows public-source Medicare data for Ali Reza Tabassian, M.D., PH.D. (NPI 1679535538), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ali Reza Tabassian, M.D., PH.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ali Reza Tabassian, M.D., PH.D.?

Ali Reza Tabassian, M.D., PH.D. is linked to VIRGINIA EYE CONSULTANTS INC (billing NPI 1992727820) in the available physician profile data.

Does Ali Reza Tabassian, M.D., PH.D. have Open Payments data?

Ali Reza Tabassian, M.D., PH.D. has 9 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.